Biotechnology Fund Class Fund Quote
| RYBOX Fund | USD 72.44 0.16 0.22% |
PerformanceSolid
| Odds Of DistressLow
|
Biotechnology Fund is trading at 72.44 as of the 6th of December 2025; that is 0.22% up since the beginning of the trading day. The fund's open price was 72.28. Biotechnology Fund has less than a 15 % chance of experiencing some financial distress in the next two years of operation and had a solid performance during the last 90 days. The performance scores are derived for the period starting the 7th of September 2025 and ending today, the 6th of December 2025. Click here to learn more.
Under normal circumstances, the fund invests substantially all of its net assets in equity securities of Biotechnology Companies that are traded in the United States and in derivatives, which primarily consist of futures contracts and options on securities, futures contracts, and stock indices. More on Biotechnology Fund Class
Moving against Biotechnology Mutual Fund
Biotechnology Mutual Fund Highlights
| Fund Concentration | Rydex Funds, Large Funds, Health Funds, Health, Rydex Funds, Large, Health (View all Sectors) |
| Update Date | 31st of December 2025 |
| Expense Ratio Date | 1st of August 2025 |
| Fiscal Year End | March |
Biotechnology Fund Class [RYBOX] is traded in USA and was established 6th of December 2025. Biotechnology Fund is listed under Rydex Funds category by Fama And French industry classification. The fund is listed under Health category and is part of Rydex Funds family. This fund at this time has accumulated 99.97 M in assets with minimum initial investment of 2.5 K. Biotechnology Fund Class is currently producing year-to-date (YTD) return of 4.4%, while the total return for the last 3 years was 3.85%.
Check Biotechnology Fund Probability Of Bankruptcy
Instrument Allocation
Sector Allocation
Investors will always prefer to have their portfolios divercified against different sectors. The broad sector allocation increases the possibility of making a profit or at least avoiding a loss. However, this may also reduce the expected return on Biotechnology Mutual Fund. Generally, it depends on diversification level and type but usually, the broader the sector allocation, the less risk can be expected from holding Biotechnology Mutual Fund, and the less return is expected.
Institutional investors that are interested in enforcing a sector tilt in their portfolio can use exchange-traded funds, such as Biotechnology Fund Class Mutual Fund, as a low-cost alternative to building a custom portfolio. So, using sector ETFs to diversify your portfolio can be a profitable strategy. However, no matter what sectors are desirable at a given time, no single industry should ever make up more than 20 percent of your stock portfolio.
Top Biotechnology Fund Class Mutual Fund Constituents
| NKTR | Nektar Therapeutics | Stock | Health Care | |
| IQV | IQVIA Holdings | Stock | Health Care | |
| VRTX | Vertex Pharmaceuticals | Stock | Health Care | |
| REGN | Regeneron Pharmaceuticals | Stock | Health Care | |
| MRNA | Moderna | Stock | Health Care | |
| INCY | Incyte | Stock | Health Care | |
| ILMN | Illumina | Stock | Health Care | |
| ABBV | AbbVie Inc | Stock | Health Care |
Biotechnology Fund Class Risk Profiles
| Mean Deviation | 0.8828 | |||
| Semi Deviation | 0.703 | |||
| Standard Deviation | 1.11 | |||
| Variance | 1.24 |
Biotechnology Fund Against Markets
Other Information on Investing in Biotechnology Mutual Fund
Biotechnology Fund financial ratios help investors to determine whether Biotechnology Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotechnology with respect to the benefits of owning Biotechnology Fund security.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |